These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 18202417)

  • 1. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma.
    Dantonello TM; Int-Veen C; Winkler P; Leuschner I; Schuck A; Schmidt BF; Lochbuehler H; Kirsch S; Hallmen E; Veit-Friedrich I; Bielack SS; Niggli F; Kazanowska B; Ladenstein R; Wiebe T; Klingebiel T; Treuner J; Koscielniak E
    J Clin Oncol; 2008 Jan; 26(3):406-13. PubMed ID: 18202417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
    Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
    Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
    Mattke AC; Bailey EJ; Schuck A; Dantonello T; Leuschner I; Klingebiel T; Treuner J; Koscielniak E
    Pediatr Blood Cancer; 2009 Jul; 52(7):772-6. PubMed ID: 19165889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
    J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL; Anderson J; Pappo AS; Meyer WH;
    J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
    Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
    J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after recurrence of osteosarcoma: a 20-year experience at a single institution.
    Crompton BD; Goldsby RE; Weinberg VK; Feren R; O'Donnell RJ; Ablin AR
    Pediatr Blood Cancer; 2006 Sep; 47(3):255-9. PubMed ID: 16123980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment of rhabdomyosarcomas (RMS) in children. A report of the Cooperative Soft Tissue Sarcoma Study (CWS-81) of the Society of Pediatric Oncology].
    Treuner J; Kaatsch P; Anger Y; Seipp A; Spaar HJ; Gerein V; Suder J; Niethammer D
    Klin Padiatr; 1986; 198(3):208-17. PubMed ID: 3523026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rhabdomyosarcoma in the area of the head-neck. A synopsis of some cases, therapeutic possibilities and prognoses].
    Hess A; Schröder U; Schröder R; Michel O
    Laryngorhinootologie; 1998 Oct; 77(10):557-63. PubMed ID: 9842519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
    Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
    J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
    Bacci G; Longhi A; Ferrari S; Mercuri M; Barbieri E; Bertoni F; Bacchini P; Picci P
    Eur J Surg Oncol; 2006 Nov; 32(9):974-9. PubMed ID: 16621429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
    Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
    Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma.
    Dantonello TM; Int-Veen C; Schuck A; Seitz G; Leuschner I; Nathrath M; Schlegel PG; Kontny U; Behnisch W; Veit-Friedrich I; Kube S; Hallmen E; Kazanowska B; Ladenstein R; Paulussen M; Ljungman G; Bielack SS; Klingebiel T; Koscielniak E;
    Pediatr Blood Cancer; 2013 Aug; 60(8):1267-73. PubMed ID: 23418028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation.
    Punyko JA; Mertens AC; Baker KS; Ness KK; Robison LL; Gurney JG
    Cancer; 2005 Apr; 103(7):1475-83. PubMed ID: 15712283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.